Industry & Business

Allergan reports rise in quarterly revenues

 Breaking News
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...
  • EIB Loan Will Trigger €180 Million Investment Programme in Fingal Fingal County Council has signed a €70 million Framework Loan Agreement with the European Investment Bank (EIB) which will trigger a €180 million investment in strategic infrastructure projects within the county’s Capital Development Plan. This represents the first EIB support for county-wide investment in partnership with an Irish local authority for more than a decade [...]...

Allergan reports rise in quarterly revenues

May 10
16:09 2016

downloadAllergan, today reported a 48% rise in quarterly profit, led by strong sales of Botox and Restasis.

The Irish based company whose $160 billion merger with Pfizer fell apart last month,reported a better than expected quarterly profit.

Allergan was known as Actavis until it bought Botox-maker Allergan last year and took on its name.

It also said today that its board had authorised a new share buyback programme of up to $10 billion.

The buyback follows Allergan’s agreement to sell its generic drug business to Teva Pharmaceutical Industries Ltd for $40.5 billion. That deal is expected to close in June. The company’s shares were up slightly in premarket trading.

Allergan’s chief executive Brent Saunders said the close of the Teva deal would also allow Allergan to pay down debt, helping it maintain its investment rating, while preserving “significant firepower” to invest for growth.

Up to Monday’s close of $213.71, Allergan’s shares had fallen about 23 per cent since Pfizer scrapped the merger, which would have been the biggest-ever in the pharmaceutical sector. The deal collapsed after the US Treasury issued new rules curbing tax inversions, under which American companies move their domicile overseas to cut taxes.

Allegan said revenue in its US brands business, which includes Botox and Restasis, rose 27.3 per cent to $2.30 billion in the first quarter ended March 31. The unit accounts for about 60 per cent of the company’s total revenue.

Allergan reported net income attributable to ordinary shareholders of $186.1 million, or 47 cents per share, compared with a loss of $535.2 million, or $1.85 per share, a year earlier. Excluding items, the company earned $3.04 per share, slightly above the average analysts’ estimate of $3.01, according to Thomson Reuters I/B/E/S. Total revenue rose 48 per cent to about $3.80 billion, short of the average estimate of $3.95 billion.

Source: Reuters

About Author

admin

admin

Related Articles






New Subscriber





Subscribe Here



Advertisements
































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4